SURAKSHA
Start SIP
Invest Now
Start SIP in SURAKSHA
Performance
- Low
- ₹284
- High
- ₹294
- 52 Week Low
- ₹231
- 52 Week High
- ₹353
- Open Price₹285
- Previous Close₹287
- Volume16,003
- 50 DMA₹278.14
- 100 DMA₹286.75
- 200 DMA₹298.42
Investment Returns
- Over 1 Month + 3.71%
- Over 3 Month -10.81%
- Over 6 Month -4.41%
- Over 1 Year -17.87%
Smart Investing Starts Here Start SIP with Suraksha Diagnostic for Steady Growth!
Suraksha Diagnostic Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 44.6
- PEG Ratio
- 6.4
- Market Cap Cr
- 1,485
- P/B Ratio
- 6.4
- Average True Range
- 8.83
- EPS
- 6.39
- Dividend Yield
- 0
- MACD Signal
- 0.5
- RSI
- 60.67
- MFI
- 72.68
Suraksha Diagnostic Financials
Suraksha Diagnostic Technicals
EMA & SMA
Current Price
₹285.10
-2.3
(-0.8%)
- Bearish Moving Average 6
- Bullish Moving Average 10
- 20 Day
- ₹275.94
- 50 Day
- ₹278.14
- 100 Day
- ₹286.75
- 200 Day
- ₹298.42
Resistance and Support
287.65
- R3 301.45
- R2 297.70
- R1 291.40
- S1 281.35
- S2 277.60
- S3 271.30
Suraksha Diagnostic Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-05 | Quarterly Results | |
| 2025-11-10 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-05-28 | Audited Results & Final Dividend | |
| 2025-02-08 | Quarterly Results |
Suraksha Diagnostic F&O
About Suraksha Diagnostic
- NSE Symbol
- SURAKSHA
- BSE Symbol
- 544293
- Joint Managing Director & CEO
- Ms. Ritu Mittal
- ISIN
- INE877V01027
Similar Stocks to Suraksha Diagnostic
Suraksha Diagnostic FAQs
Suraksha Diagnostic share price is ₹285 As on 10 February, 2026 | 22:49
The Market Cap of Suraksha Diagnostic is ₹1484.8 Cr As on 10 February, 2026 | 22:49
The P/E ratio of Suraksha Diagnostic is 44.6 As on 10 February, 2026 | 22:49
The PB ratio of Suraksha Diagnostic is 6.4 As on 10 February, 2026 | 22:49
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.